SCHEMBL25925882

SCHEMBL25925882

Cn1nccc1/N=N/c1cc(O)c(O)c(/N=N/c2ccnn2C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.36
MAPT P10636 8/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
HTT P42858 3/20 0.34
TDP1 Q9NUW8 3/20 0.34
AGTR1 P30556 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
KCNH2 Q12809 1/20 0.33
EGFR P00533 1/20 0.33
MAPK1 P28482 4/20 0.32
RAB9A P51151 4/20 0.32
KDM4E B2RXH2 2/20 0.32
HSP90AA1 P07900 2/20 0.32
OPRK1 P41145 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925890 0.88 PTGS2 (0.49) MAPTMEN1KMT2ATDP1L3MBTL1
SCHEMBL25925895 0.86 AHR (0.32) AHRL3MBTL1HSP90AA1
SCHEMBL25925933 0.84 PTGS1 (0.41) AHRMAPTMEN1KMT2AHTT
SCHEMBL25925883 0.83
SCHEMBL25925862 0.82 MAPT (0.34) AHRMAPTMEN1KMT2AHTT
SCHEMBL18250390 0.79 KMT2A (0.49) AHRMAPTMEN1KMT2AHTT
SCHEMBL16232517 0.78 PTGS1 (0.46) AHRMAPTMEN1KMT2AHTT
SCHEMBL25925873 0.78 RAB9A (0.36) AHRMAPTMEN1KMT2AL3MBTL1
SCHEMBL25925911 0.77 EGFR (0.49) MAPTMEN1KMT2AHTTTDP1
SCHEMBL25925733 0.76 ALDH1A1 (0.36) MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 AHR 725/4885MAPT 2/4885MEN1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.